Avectas Ltd., to Present at the Biotech Showcase™ Annual Conference on January 8th, 2018
Dublin, 02/01/2017 – Avectas, a biotechnology company, developing a novel vector-free cell engineering technology today announced it will present a corporate overview at Biotech Showcase 2018, during the course of one of the industry's largest annual healthcare investor meetings, J.P. Morgan Annual Healthcare Conference, in San Francisco on January 8th.
Dr. Michael Maguire, CEO will present at the Biotech Showcase™ as follows:
Date: Monday, January 8th, 2018
Time: 2.00 pm (PST)
Room: Franciscan - C (Ballroom Level)
Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA (United States)
Our ambition is to be the market leading vector-free delivery technology for next-generation cell and gene therapies. Avectas is a biotechnology company developing Solupore®, a novel vector-free cell engineering technology addressing challenges in intracellular delivery and manufacturing in the immuno-oncology space including CAR-T and gene editing.
About the Biotech Showcase™:
The Biotech Showcase™ produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to private and public biotechnology and life sciences companies during the course of one of the industry's largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.
Sara Demy-Colton, CEO of Demy-Colton, said: “We are delighted that Avectas will be presenting at Biotech Showcase this year. Biotech Showcase is the perfect platform for life science companies to showcase their innovation and seek out their next deal. This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2018.”
Director of Business Development
More information: www.avectas.com
Additional links and information:
Follow Avectas on Twitter: @Avectas
Follow Biotech Showcase on Twitter: @EBDGroup and @Demy_Colton - #BiotechShowcase